Gramse Pharmaceuticals Ltd.
Gramse Pharmaceuticals Ltd, headquartered in Yokneam, Israel, is a leading independent importer and marketer of high-quality, generic and proprietary pharmaceuticals to the Israeli market.
Incorporated in 1963, the company has developed local presence marketing its products to the Israeli HMOs, hospitals and the private sector.
Gramse focuses mainly on the following therapeutic segments.
|  |
- Cardiovascular
- Neurology
- Ophthalmology
- Dentistry
- Food supplements
Gramse's main goal is to maintain a healthy, top line growth as well as strengthen its local presence. Company History - 1938 - Mr. Walter Gramse, a young immigrant from Germany, opened a pharmacy called Mazor (Hebrew for cure) in Ramat-Gan, where he formulated products that were needed in the Israeli market.
- 1963 - Mr. Gramse established the Gramse Company and began importing pharmaceuticals from Europe and the USA. The company gained the recognition of major HMOs and hospitals.
- 1998 - Gramse's shares were acquired by Balgay Holdings Ltd., a company in the field of biotechnology and industrial enzymes.
- 2000 - Gramse Pharmaceuticals moved to its new headquarters in the industrial zone for advanced technologies in Yokneam, northern Israel.
- 2004, the company received approval to import Oxytocin, a pharmaceutical product for hospitals.
- 2005 - Gramse was granted approval to import two new food supplements, Alpenkraft and Coenzyme Q-10.
Displaying 1 to 3 (of 3 products)
Displaying 1 to 3 (of 3 products)
|
